Dr. Zeng joined the Buck Institute in 2005. Her laboratory focuses on potential treatments and therapies for Parkinson’s disease. Before arriving at the Buck Institute, Dr. Zeng earned a PhD in Molecular Biology at the Technical University of Denmark followed by postdoctoral training on embryonic stem cells at the National Institutes of Health. After establishing her laboratory, Dr. Zeng was awarded a prestigious grant from the California Institute for Regenerative Medicine to spearhead the development of a stem cell-based treatment for Parkinson’s disease. After years of dedicated work creating the cell lines and collaborating on a delivery system the Zeng laboratory and their industry collaborators have developed a stem cell based treatment that is ready for human clinical trials.